Canna~Fangled Abstracts Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain. Int J Mol Sci. 2020 Feb 20;21(4). pii: E1423. doi: 10.3390/ijms21041423. Hossain MZ1, Ando H2,…Freedom WaresFebruary 20, 2020
